nach oben

Erschienen in:

02.03.2020 | Original Article

Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP

verfasst von: David-Dan Nguyen, Vincent Misraï, Thorsten Bach, Naeem Bhojani, James E. Lingeman, Dean S. Elterman, Kevin C. Zorn

Erschienen in: World Journal of Urology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The BPH surgical armamentarium is composed of a rapidly expanding number of technologies and techniques. These include greenlight photovaporization of the prostate (PVP), greenlight enucleation of the prostate (GreenLEP), holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP) and, more recently, the aquablation procedure. To the best of our knowledge, no direct comparison in operative time has been performed.

Methods

Data for this study were pooled from five sources. For aquablation, patient-level data from four studies of the aquablation procedure were provided by the device manufacturer as well as from a high-volume commercial user. PVP, GreenLEP, HoLEP, and ThuLEP were performed by high-volume, experienced experts. Endpoints included total operative time, resection time, and proportion of total operative time for resection. General linear models were used to evaluate the relationship between prostate volume (or other continuous predictors) and procedure time.

Results

Total procedure time was related to prostate size. Except for the small prostate size range (size < 40 cc), at any given prostate volume, procedure time was highest for PVP, intermediate for LEPs, and lowest for Aquablation. The relationship between procedure time and prostate size (i.e., slope of the fitted lines) was 0.16 min/g for aquablation, 0.32 min/g, 0.28 min/g and 0.32 min/g for GreenLEP, HoLEP and ThuLEP, respectively, and 0.63 min/g for PVP.

Conclusion

In our analysis of pooled data of multi-surgical techniques and technologies, aquablation provided the lowest operative time across all prostate volumes. PVP had the longest procedure time for prostates > 40 cc.

Lue TF, McAninch JW (eds) (2013) Smith & Tanagho's general urology. McGraw-Hill Medical

Vuichoud C, Loughlin KR (2015) Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 22(Suppl 1):1–6PubMed

Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, Lerner LB, Lightner DJ, Parsons JK, Roehrborn CG, Welliver C, Wilt TJ, McVary KT (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200(3):612–619CrossRef

Nickel JC, Aaron L, Barkin J, Elterman D, Nachabé M, Zorn KC (2018) Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. Can Urol Assoc J 12(10):303–312. https://doi.org/10.5489/cuaj.5616CrossRefPubMedPubMedCentral

Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038CrossRefPubMed

Kuntz RM (2006) Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 49(6):961–969. https://doi.org/10.1016/J.EURURO.2006.03.028CrossRefPubMed

Le Duc A, Gilling PJ (1999) Holmium laser resection of the prostate. Eur Urol 35(2):155–160. https://doi.org/10.1159/000019836CrossRefPubMed

Wilson LC, Gilling PJ, Williams A et al (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 50(3):569–573. https://doi.org/10.1016/J.EURURO.2006.04.002CrossRefPubMed

Krambeck AE, Handa SE, Lingeman JE (2010) Experience with more than 1000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 183(3):1105–1109. https://doi.org/10.1016/j.juro.2009.11.034CrossRefPubMed

10.

Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. https://doi.org/10.1016/J.EURURO.2010.06.005CrossRefPubMed

11.

Herrmann TRW, Bach T, Imkamp F et al (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 28(1):45–51. https://doi.org/10.1007/s00345-009-0503-0CrossRefPubMed

12.

Bach T, Netsch C, Haecker A, Michel M-S, Herrmann TRW, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39–43. https://doi.org/10.1007/s00345-009-0461-6CrossRefPubMed

13.

Sachs B, Misrai V, Tabatabaei S, Woo HH (2019) Multicenter experience with photoselective vaporization of the prostate on men taking novel oral anticoagulants. Asian J Urol. https://doi.org/10.1016/J.AJUR.2019.07.005CrossRefPubMedPubMedCentral

14.

Hueber PA, Liberman D, Ben-Zvi T, Woo H, Hai MA, Te AE, Chughtai B, Lee R, Rutman M, Gonzalez RR, Barber N, Al-Hathal N, Al-Qaoud T, Trinh QD, Zorn KC (2013) 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 82(5):1108–1113CrossRef

15.

Thomas JA, Tubaro A, Barber N et al (2016) A multicenter randomized noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69(1):94–102CrossRef

16.

Ajib K, Mansour M, Zanaty M et al (2018) Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J 12(7):E318–E324. https://doi.org/10.5489/cuaj.4895CrossRefPubMedPubMedCentral

17.

Huet R, Mathieu R, Verhoest G, Bensalah K, Vincendeau S (2015) Énucléation prostatique au laser Greenlight (GreenLEP) versus Photovaporisation prostatique (PVP) GreenlightXPS 180 W pour les volumes de %3e 80 mL : étude monocentrique comparative et prospective des résultats péri-opératoires et fonctionnels à moyen terme. Progrès en Urol 25(13):732. https://doi.org/10.1016/J.PUROL.2015.08.034CrossRef

18.

Elshal AM, Elkoushy MA, El-Nahas AR et al (2015) GreenLight^TM Laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 193(3):927–934. https://doi.org/10.1016/J.JURO.2014.09.097CrossRefPubMed

19.

Gilling PJ, Barber N, Bidair M et al (2019) Randomized controlled trial of aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia: one-year outcomes. Urology 125:169–173. https://doi.org/10.1016/J.UROLOGY.2018.12.002CrossRefPubMed

20.

Gilling P, Barber N, Bidair M et al (2018) WATER: a double-blind, randomized, controlled trial of aquablation vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252–1261. https://doi.org/10.1016/j.juro.2017.12.065CrossRefPubMed

21.

Desai M, Bidair M, Bhojani N et al (2018) WATER II (80–150 mL) procedural outcomes. BJU Int. https://doi.org/10.1111/bju.14360CrossRefPubMed

22.

Misrai V, Rijo E, Zorn KC, Barry-Delongchamps N, Descazeaud A (2019) Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first french aquablation clinical registry. Eur Urol. https://doi.org/10.1016/J.EURURO.2019.06.024CrossRefPubMed

23.

Bach T, Giannakis I, Bachmann A et al (2018) Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort. World J Urol. https://doi.org/10.1007/s00345-018-2509-yCrossRefPubMed

24.

Azizi M, Tholomier C, Meskawi M et al (2017) Safety, perioperative, and early functional outcomes of vapor incision technique using the greenlight XPS 180 W system: direct comparison with photoselective vaporization of the prostate. J Endourol 31(1):43–49. https://doi.org/10.1089/end.2016.0474CrossRefPubMed

25.

Gomez Sancha F, Rivera VC, Georgiev G, Botsevski A, Kotsev J, Herrmann T (2015) Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol 33(4):539–547. https://doi.org/10.1007/s00345-014-1339-9CrossRefPubMed

26.

Bhojani N, Nguyen D-DD, Kaufman RP, Elterman D, Zorn KC (2019) Comparison of %3c 100 cc prostates and %3e 100 cc prostates undergoing aquablation for benign prostatic hyperplasia. World J Urol 37(7):1361–1368. https://doi.org/10.1007/s00345-018-2535-9CrossRefPubMed

Titel: Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP
verfasst von: David-Dan Nguyen
Vincent Misraï
Thorsten Bach
Naeem Bhojani
James E. Lingeman
Dean S. Elterman
Kevin C. Zorn
Publikationsdatum: 02.03.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 12/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-020-03137-8

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort

RE Re Do urethroplasty after multiple failed surgeries of pelvic fracture urethral injury

Genitourinary reconstruction

The 365 μm holmium laser in flexible ureteroscopic lithotripsy: prospect and risk coexist?

Can we count on popcorn technique in lithotripsy: based on recent in vitro studies?